Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131486) titled 'Isolation and Structural Identification of Human Anti-PEG Pre-existing Antibodies' on Sept. 3.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Jing'an District Central Hospital Of Shanghai

Condition: None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-14

Target Sample Size: Observation group:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=340958

Disclaimer: Curated by HT Syndication....